Cart
sales@molnova.com
Glyasperin A
CAS No. 142474-52-0
Glyasperin A( —— )
Catalog No. M30867 CAS No. 142474-52-0
Glyasperin A has cytotoxic properties against P-388 cells, its IC50 values being 6.0 microM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 745 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlyasperin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlyasperin A has cytotoxic properties against P-388 cells, its IC50 values being 6.0 microM.
-
DescriptionGlyasperin A has cytotoxic properties against P-388 cells, its IC50 values being 6.0 microM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142474-52-0
-
Formula Weight422.5
-
Molecular FormulaC25H26O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK2807 Trifluoroace...
GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).GSK2807, a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM).?A high-resolution crystal structure reveals that GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3.
-
Rozanolixizumab
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
-
Tyr-Leptin (26-39) (...
Tyr-Leptin (26-39) (human)
